These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35124909)

  • 1. Contrast Induced Nephropathy In High Risk Patients - Myth Or Reality.
    Nabi Z; Anjum N; Rashid RM; Zahideen ZU
    J Ayub Med Coll Abbottabad; 2021; 33(4):568-571. PubMed ID: 35124909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
    Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
    Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
    Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
    Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
    Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-Induced Nephropathy in STEMI Patients With and Without Chronic Kidney Disease.
    Jain T; Shah S; Shah J; Jacobsen G; Khandelwal A
    Crit Pathw Cardiol; 2018 Mar; 17(1):25-31. PubMed ID: 29432373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
    Worasuwannarak S; Pornratanarangsi S
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
    Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
    Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.
    Chong E; Shen L; Poh KK; Tan HC
    Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography.
    Mehran R; Faggioni M; Chandrasekhar J; Angiolillo DJ; Bertolet B; Jobe RL; Al-Joundi B; Brar S; Dangas G; Batchelor W; Prasad A; Gurm HS; Tumlin J; Stone GW
    JACC Cardiovasc Interv; 2018 Aug; 11(16):1601-1610. PubMed ID: 30139467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-Arterial versus Intravenous Contrast and Renal Injury in Chronic Kidney Disease: A Propensity-Matched Analysis.
    Chaudhury P; Armanyous S; Harb SC; Ferreira Provenzano L; Ashour T; Jolly SE; Arrigain S; Konig V; Schold JD; Navaneethan SD; Nally JV; Nakhoul GN
    Nephron; 2019; 141(1):31-40. PubMed ID: 30368506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use and efficacy of saline hydration and N-acetyl cysteine to prevent contrast-induced nephropathy in low-risk populations undergoing coronary artery angiography.
    Calabrò P; Bianchi R; Crisci M; Caprile M; Bigazzi MC; Palmieri R; Golia E; De Vita A; Romano IJ; Limongelli G; Russo MG; Calabrò R
    Intern Emerg Med; 2011 Dec; 6(6):503-7. PubMed ID: 21279477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast induced nephropathy in patients with pre-existing renal impairment undergoing coronary angiogram and percutaneous transluminal coronary angioplasty.
    Subedi B; Siddique MA; Zaman SM; Hasan MI; Arzu J; Awal A; Fatema K
    Mymensingh Med J; 2011 Apr; 20(2):270-4. PubMed ID: 21522099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
    Garcia S; Ko B; Adabag S
    Ann Thorac Surg; 2012 Sep; 94(3):772-6. PubMed ID: 22835553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-Induced Nephropathy: From Pathophysiology to Preventive Strategies.
    Azzalini L; Spagnoli V; Ly HQ
    Can J Cardiol; 2016 Feb; 32(2):247-55. PubMed ID: 26277092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.
    Toso A; Maioli M; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Manzone C; Amato M; Bellandi F
    Am J Cardiol; 2010 Feb; 105(3):288-92. PubMed ID: 20102936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Syndrome and the Iodine-Dose/Creatinine Clearance Ratio as Determinants of Contrast-Induced Acute Kidney Injury.
    Amiri A; Ghanavati R; Riahi Beni H; Sezavar SH; Sheykhvatan M; Arab M
    Cardiorenal Med; 2018; 8(3):217-227. PubMed ID: 29909417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevention of contrast-induced nephropathy by simultaneous hemofiltration during coronary angiographic procedures: a comparison with periprocedural hemofiltration.
    Choi MJ; Yoon JW; Han SJ; Choi HH; Song YR; Kim SG; Oh JE; Lee YK; Seo JW; Kim HJ; Noh JW; Koo JR
    Int J Cardiol; 2014 Oct; 176(3):941-5. PubMed ID: 25200848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (First study for REduction of contraSt-induCed nephropathy followINg carDiac catheterization) trial.
    Liu Y; Chen JY; Huo Y; Ge JB; Xian Y; Duan CY; Chen SQ; Jiang W; Chen PY; Tan N;
    Am Heart J; 2016 Feb; 172():88-95. PubMed ID: 26856220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National Cardiovascular Data Registry-Acute Kidney Injury (NCDR) vs. Mehran risk models for prediction of contrast-induced nephropathy and need for dialysis after coronary angiography in a German patient cohort.
    Parco C; Brockmeyer M; Kosejian L; Quade J; Tröstler J; Bader S; Lin Y; Sokolowski A; Hoss A; Heinen Y; Schulze V; Icks A; Jung C; Kelm M; Wolff G
    J Nephrol; 2021 Oct; 34(5):1491-1500. PubMed ID: 34363595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of vascular access on the development of contrast induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention.
    Barbieri L; Verdoia M; Suryapranata H; De Luca G;
    Int J Cardiol; 2019 Jan; 275():48-52. PubMed ID: 30274753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.